159 related articles for article (PubMed ID: 9487328)
1. Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study.
Karlberg KE; Saldeen T; Wallin R; Henriksson P; Nyquist O; Sylvén C
J Intern Med; 1998 Jan; 243(1):25-31. PubMed ID: 9487328
[TBL] [Abstract][Full Text] [Related]
2. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Smith TW; Antman EM
Circulation; 1988 Apr; 77(4):787-94. PubMed ID: 3127076
[TBL] [Abstract][Full Text] [Related]
3. Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Antman EM; Smith TW
Eur Heart J; 1988 Jan; 9 Suppl A():95-100. PubMed ID: 3137075
[TBL] [Abstract][Full Text] [Related]
4. [Diltiazem versus intravenous nitroglycerin in the treatment of unstable angina pectoris. A randomized study].
Castro P; Corbalán R; Vergara I; Kunstmann S
Rev Med Chil; 1995 Jul; 123(7):823-9. PubMed ID: 8560112
[TBL] [Abstract][Full Text] [Related]
5. Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction.
Horowitz JD
Am J Med; 1991 Sep; 91(3C):113S-117S. PubMed ID: 1928201
[TBL] [Abstract][Full Text] [Related]
6. Effect of magnesium sulphate in patients with unstable angina. A double blind, randomized, placebo-controlled study.
Redwood SR; Bashir Y; Huang J; Leatham EW; Kaski JC; Camm AJ
Eur Heart J; 1997 Aug; 18(8):1269-77. PubMed ID: 9458419
[TBL] [Abstract][Full Text] [Related]
7. Nitroglycerin tolerance at the platelet level in patients with angina pectoris.
Chirkov YY; Chirkova LP; Horowitz JD
Am J Cardiol; 1997 Jul; 80(2):128-31. PubMed ID: 9230146
[TBL] [Abstract][Full Text] [Related]
8. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
Schulman SP; Goldschmidt-Clermont PJ; Topol EJ; Califf RM; Navetta FI; Willerson JT; Chandra NC; Guerci AD; Ferguson JJ; Harrington RA; Lincoff AM; Yakubov SJ; Bray PF; Bahr RD; Wolfe CL; Yock PG; Anderson HV; Nygaard TW; Mason SJ; Effron MB; Fatterpacker A; Raskin S; Smith J; Brashears L; Gottdiener P; du Mee C; Kitt MM; Gerstenblith G
Circulation; 1996 Nov; 94(9):2083-9. PubMed ID: 8901655
[TBL] [Abstract][Full Text] [Related]
9. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization.
Patel DJ; Purcell HJ; Fox KM
Eur Heart J; 1999 Jan; 20(1):51-7. PubMed ID: 10075141
[TBL] [Abstract][Full Text] [Related]
11. Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction.
Diodati J; Théroux P; Latour JG; Lacoste L; Lam JY; Waters D
Am J Cardiol; 1990 Sep; 66(7):683-8. PubMed ID: 2119139
[TBL] [Abstract][Full Text] [Related]
12. Safety profile and tolerability of intravenous AR-C69931MX, a new antiplatelet drug, in unstable angina pectoris and non-Q-wave myocardial infarction.
Jacobsson F; Swahn E; Wallentin L; Ellborg M
Clin Ther; 2002 May; 24(5):752-65. PubMed ID: 12075943
[TBL] [Abstract][Full Text] [Related]
13. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
14. Impact of preoperative intravenous nitroglycerin on in-hospital outcomes after coronary artery bypass grafting for unstable angina.
Ali IS; Buth KJ; Maitland A
Am Heart J; 2004 Oct; 148(4):727-32. PubMed ID: 15459607
[TBL] [Abstract][Full Text] [Related]
15. Antianginal effects of intravenous nitroglycerin over 24 hours.
Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
[TBL] [Abstract][Full Text] [Related]
16. Effect of transdermal nitroglycerin or N-acetylcysteine, or both, in the long-term treatment of unstable angina pectoris.
Ardissino D; Merlini PA; Savonitto S; Demicheli G; Zanini P; Bertocchi F; Falcone C; Ghio S; Marinoni G; Montemartini C; Mussini A
J Am Coll Cardiol; 1997 Apr; 29(5):941-7. PubMed ID: 9120179
[TBL] [Abstract][Full Text] [Related]
17. Comparable effects of intravenous nitroglycerin and intravenous nitroprusside in acute ischemia.
Breisblatt WM; Navratil DL; Burns MJ; Spaccavento LJ
Am Heart J; 1988 Aug; 116(2 Pt 1):465-72. PubMed ID: 3135734
[TBL] [Abstract][Full Text] [Related]
18. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
Kośmicki MA; Szwed H; Sadowski Z
Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
[TBL] [Abstract][Full Text] [Related]
19. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris.
Göbel EJ; Hautvast RW; van Gilst WH; Spanjaard JN; Hillege HL; DeJongste MJ; Molhoek GP; Lie KI
Lancet; 1995 Dec 23-30; 346(8991-8992):1653-7. PubMed ID: 8551821
[TBL] [Abstract][Full Text] [Related]
20. Bolus i.v. nitroglycerin treatment of ischemic chest pain in the ED.
Nashed AH; Allegra JR; Larsen S; Horowitz M
Am J Emerg Med; 1994 May; 12(3):288-91. PubMed ID: 8179732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
